Rx Import Bill Undercuts FDA Approach To Quality Control, Lilly Exec Testifies

FDA's process focus in GMP regulation illustrates the importance of manufacturer control over importation into the U.S., Lilly Europe/North America Area Quality Control Leader Nikki Mehringer told the House Commerce/Oversight Subcommittee Oct. 3.

More from Archive

More from Pink Sheet